400
Participants
Start Date
February 1, 2018
Primary Completion Date
May 1, 2019
Study Completion Date
May 1, 2019
Active Elipse Device
Intervention Device
Elipse Sham Device
Control Device
Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism, New York
University of Pennsylvania Medical Center (UPMC), Pittsburgh
Charlottesville Medical Research Center, Charlottesville
Vanderbilt Center for Surgical Weight Loss, Nashville
CHI Metabolic and Bariatric Care, Chattanooga
MidSouth Bariatrics, Memphis
Bariatric Institute of Greater Chicago, Bolingbrook
Surgical Specialists of Louisiana, Metairie
UT Physicians Minimally Invasive Surgeons of Texas (UTMIST), Bellaire
University of Colorado, Anschutz Health and Wellness Center, Aurora
Honor Health, Scottsdale
Holyoke Medical Center, Holyoke
Lead Sponsor
Allurion Technologies
INDUSTRY